Melissa Gallo MS.ED
Behavioral Analyst
4 NESHAMINY INTERPLEX DR STE 202 FEASTERVILLE TREVOSE PA, 19053About
Melissa Gallo MS.ED is a top Behavioral Analyst in FEASTERVILLE TREVOSE, PA. With a passion for the field and an unwavering commitment to their specialty, Melissa Gallo MS.ED is an expert in changing the lives of their patients for the better. Through their designated cause and expertise in the field, Melissa Gallo MS.ED is a prime example of a true leader in health care. As a leader and expert in their field, Melissa Gallo MS.ED is passionate about enhancing patient quality of life. They embody the values of communication, safety, and trust when dealing directly with patients. In FEASTERVILLE TREVOSE, PA, Melissa Gallo MS.ED is a true asset to their field and dedicated to the profession of medicine.
Provider Details
Melissa Gallo MS.ED's Practice location
FEASTERVILLE TREVOSE, PA 19053Get Direction
Melissa Gallo MS.ED's reviews
Write ReviewRecommended Articles
- How Often Should a Newborn Poop?
First-time parents may wonder how often their newborn should poop and what a normal newborn poop would look like. A baby’s health can be best indicated by a baby’s bowel movement, but new parents may not know what to expect. For this reason, new parents become unsure and apprehensive during...
- All About Plantar Warts
How do plantar warts form?Verruca Plantaris is the technical name for plantar warts. What are they? Warts are small benign (non-cancerous) growths on the skin. They typically occur when the skin is infected by a virus. In this case, plantar warts are caused by the human papillomavirus (HPV). This...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis
On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...
- Gastroenteritis: The Treatment Options
Treatments for gastroenteritis vary depending on the underlying cause. Normally, acute gastritis caused by non-steroidal anti-inflammatory medications and alcohol can be lessened by stopping the usage of such substances. On the other hand, chronic arthritis occurs due to an H. pylori infection,...
- Gastric Bypasses in Diabetic Patients May Reduce Long-Term Mortality Rates
For a long time, diabetes has been one of the most dangerous diseases when left untreated. This condition alters the way in which the body produces and reacts to insulin, the hormone which helps regulate blood sugar levels and plays a vital role in the person’s metabolism. Type 2 diabetes, the...